Johnson & Johnson SWOT Analysis
This is an excerpt from the paper...
Johnson & Johnson is the world's most comprehensive and broadly based health care product manufacturer with more than 200 operating companies in 57 countries (Our company, 2004). Among its many strengths are its position in the United States as a company with the "best corporate reputation (General information, 2004). With worldwide sales of $41.9 billion and net earnings of $7.2 billion in 2003, the firm has generated dividends for shareholders every quarter since 1944 and dividends have been raised each year for 42 consecutive years (General information, 2004). Johnson & Johnson, according to Hamer (2004), enjoys an excellent research and development pipeline, a strong position in the generic pharmaceutical sector, and the firm has successfully employed a corporate strategy of differentiation to distinguish itself from its competitors. Innovative products and diversification through company
. . .
Some common words found in the essay are:
Johnson Johnson, Johnson Hamer, Modernization Act, johnson johnson, Threats Hypercompetition, hamer 2004, Johnson Available, research development, Spring Available, 2004 johnson johnson, 2004 johnson, Opportunities Opportunities, pharmaceutical industry, information 2004, research development pipeline, medicare prescription, prescription drug, research development budget, generic drug, company 2004, johnson johnson available, johnson johnson major,
Approximate Word count = 638
Approximate Pages = 3 (250 words per page)
More Essays on Johnson & Johnson SWOT Analysis
|
Customer Service
to Over
32,000 Professionally Written Papers!!!
